Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?

Guardado en:
Detalles Bibliográficos
Autores principales: Ahmed Donia, Ramla Shahid, Muhammad Nawaz, Tahir Yaqub, Habib Bokhari
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/2ecd9f51bbf54eb393b7c8f7ccb6947e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2ecd9f51bbf54eb393b7c8f7ccb6947e
record_format dspace
spelling oai:doaj.org-article:2ecd9f51bbf54eb393b7c8f7ccb6947e2021-12-02T23:33:54ZCan we develop oncolytic SARS-CoV-2 to specifically target cancer cells?1758-835910.1177/17588359211061988https://doaj.org/article/2ecd9f51bbf54eb393b7c8f7ccb6947e2021-12-01T00:00:00Zhttps://doi.org/10.1177/17588359211061988https://doaj.org/toc/1758-8359Ahmed DoniaRamla ShahidMuhammad NawazTahir YaqubHabib BokhariSAGE PublishingarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENTherapeutic Advances in Medical Oncology, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ahmed Donia
Ramla Shahid
Muhammad Nawaz
Tahir Yaqub
Habib Bokhari
Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
format article
author Ahmed Donia
Ramla Shahid
Muhammad Nawaz
Tahir Yaqub
Habib Bokhari
author_facet Ahmed Donia
Ramla Shahid
Muhammad Nawaz
Tahir Yaqub
Habib Bokhari
author_sort Ahmed Donia
title Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
title_short Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
title_full Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
title_fullStr Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
title_full_unstemmed Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
title_sort can we develop oncolytic sars-cov-2 to specifically target cancer cells?
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/2ecd9f51bbf54eb393b7c8f7ccb6947e
work_keys_str_mv AT ahmeddonia canwedeveloponcolyticsarscov2tospecificallytargetcancercells
AT ramlashahid canwedeveloponcolyticsarscov2tospecificallytargetcancercells
AT muhammadnawaz canwedeveloponcolyticsarscov2tospecificallytargetcancercells
AT tahiryaqub canwedeveloponcolyticsarscov2tospecificallytargetcancercells
AT habibbokhari canwedeveloponcolyticsarscov2tospecificallytargetcancercells
_version_ 1718373980292775936